How Pharma Can Best Manage Third-Party Risk

Brad Gilliat, Blake Gardner, Bob Mooney
3/28/2025
How Pharma Can Best Manage Third-Party Risk

As pharma companies use more third parties, risk management must maintain compliance, quality, and reputation without slowing growth.

In this article, originally published Feb. 4, 2025, in Life Science Leader, Crowe specialists identify what’s involved in building effective third-party risk management programs.

Managing third-party risk is one of the most arduous challenges facing pharmaceutical companies, and regulatory requirements are just one piece of this puzzle.

Pharmaceutical organizations are continually evolving – rapidly. Often, this evolution involves an increased use of third parties. As changes occur, companies’ third-party risk management (TPRM) programs must continue to adapt to ensure compliance, maintain quality, and ultimately help protect the companies’ reputation. The challenge is doing so effectively without compromising growth or exposing organizations to unnecessary risk.

Read the full article on Life Science Leader

Manage third-party risk in health and sciences

We can help you identify and address increasing complexity in third-party risk. Learn more about how our specialized knowledge and experience can help.

Brad Gilliat
Brad Gilliat
Partner, Consulting,
Crowe Advisory LLC
Blake Gardner Headshot
Blake Gardner
Senior Manager, Consulting,
Crowe Advisory LLC

Related insights

loading gif
Two business professionals reviewing information on a laptop and tablet during a collaborative discussion.
When Life Sciences Companies Need Compliance Expertise
Explore when life sciences companies need compliance expertise to manage regulatory risk, support growth, and build the right capabilities.
Professionals engaged in a presentation during a business meeting.
Top Risks in Internal Audit for 2027
In this webinar recording, Crowe specialists explore risks for internal audit in 2027 and share ideas to strengthen governance and compliance.
Life sciences researchers conduct laboratory testing, highlighting operational risks relevant to internal audit planning.
Top Risk Areas for Internal Audit Planning: Life Sciences
Crowe specialists review 2027 internal audit planning for life sciences organizations, including for cybersecurity, data privacy, AI, and compliance.
Two business professionals reviewing information on a laptop and tablet during a collaborative discussion.
When Life Sciences Companies Need Compliance Expertise
Explore when life sciences companies need compliance expertise to manage regulatory risk, support growth, and build the right capabilities.
Professionals engaged in a presentation during a business meeting.
Top Risks in Internal Audit for 2027
In this webinar recording, Crowe specialists explore risks for internal audit in 2027 and share ideas to strengthen governance and compliance.
Life sciences researchers conduct laboratory testing, highlighting operational risks relevant to internal audit planning.
Top Risk Areas for Internal Audit Planning: Life Sciences
Crowe specialists review 2027 internal audit planning for life sciences organizations, including for cybersecurity, data privacy, AI, and compliance.